Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 2,473 shares at $71.49 ($177K) on 2012-05-17, disclosed to the SEC on 2012-05-21.
Open-market sale of $177k HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |